What Does ‘Healing the Brain’ Actually Mean?

What Does ‘Healing the Brain’ Actually Mean?

By J.Michelle

“Heal your brain” sounds reassuring until someone asks what, exactly, will be measured.

Does it mean fewer nightmares? Better concentration? Improved performance on a cognitive test? Returning to an activity? A change on an MRI? These outcomes can all matter, but they are different outcomes. A responsible claim names the one it has evidence for.

This article distinguishes symptom improvement, functional recovery, cognitive improvement, and measured neural change. Fonzo and colleagues’ psychotherapy imaging study reports changes in cortical activity and connectivity; those reported outcomes do not by themselves establish regrowth of injured tissue or reversal of every injury type. [1] That distinction protects the meaning of the evidence rather than diminishing it.

If a person sleeps better and can attend an appointment without overwhelming distress, those improvements matter even without a scan. If imaging changes but daily life remains difficult, the image alone does not settle whether the treatment achieved the person's goals. Clinical benefit and a proposed biological explanation should be evaluated separately.

The language of neuroplasticity can become especially slippery. Even if a study demonstrates nervous-system change, that finding would not establish that a different commercial program repairs a particular injury. The program-specific claim requires its own evidence. The program still needs evidence for its actual intervention, population, comparison, and outcomes. The word mechanism is not a substitute for a treatment trial.

Readers can translate a broad promise into a clearer question: “What improvement can I reasonably look for, over what period, with what uncertainty and risks?” A credible provider should be able to discuss lack of response as well as success. A plan that explains every failure as insufficient belief or effort is difficult to evaluate honestly.

Four outcomes that should not be collapsed

Symptom improvement concerns the burden of distress or a clinical disorder. Functional recovery concerns participation in activities. Cognitive improvement concerns abilities such as learning or attention. Neural change concerns a measured feature of brain structure or activity. This article separates these outcomes because evidence for one does not automatically establish the others.

A person may feel less distressed while still needing assistance with complex tasks. Another may manage activities more successfully through an aid even if an underlying difficulty remains. A study might identify a neural change without measuring the outcome most important to the participant. These are possibilities illustrating the distinction, not claims that every treatment produces a particular combination.

The practical question is which outcome a claim names. If a programme says it heals the brain but measures only satisfaction at the end of a course, the advertised outcome and the measured outcome do not match. The same scrutiny should apply to an academic study, a commercial service, and our own descriptions of improvement.

A hypothetical treatment result with real value and clear limits

Imagine a survivor who completes treatment and reports fewer nightmares and greater ability to attend appointments. Those improvements can be meaningful. They do not, without additional evidence, establish that injured tissue has regrown or that every cognitive difficulty has resolved. Recognizing the limit should not make the improvement seem worthless.

Now imagine that a scan changes but the person reports no benefit in daily life. The measurement may be scientifically interesting, yet it does not answer whether the treatment achieved the person's goals. A responsible interpretation would report both the result and the unresolved concern, rather than treating the image as superior to the lived outcome by default.

Following the example through clarifies the next step. The clinician and patient can review the target, the measures, the person's priorities, and remaining symptoms. The purpose is not to choose between scientific data and subjective experience. It is to understand what each contributes and which further assessment or treatment discussion is appropriate.

What a mechanism can contribute

A mechanism describes a proposed or demonstrated process by which an intervention might produce an effect. It can guide research and explain why a treatment is plausible. But plausibility and clinical effectiveness are separate questions. A programme can invoke learning or neuroplasticity without having demonstrated the outcome it sells. The same evidentiary boundary should apply to proprietary approaches and other interventions.

This distinction becomes especially important when a general scientific principle is used to validate a specific package. Even if evidence establishes a learning-related change in behaviour in one study, that finding would not establish that every educational course treats PTSD. A claim about a particular course still requires evidence about that course and outcome. Evidence of treatment-associated change in cortical function does not show reversal of every injury mechanism. [1] The inference must remain connected to the actual intervention and measured population.

The countercondition is that absence of evidence is not automatically evidence of no possible benefit. A developing approach may deserve study. The ethical issue is how its present status is communicated. A hypothesis can be described as a hypothesis, and a promising intervention can be discussed with uncertainty. The reader should not be asked to purchase certainty that the research has not established.

Why guaranteed timelines distort the question

A fixed promise can sound concrete: follow this sequence and recover within a stated period. My proposed standard is to state the condition being treated and ask explicitly about the person's health, access, participation, adverse outcomes, and treatment response. Those questions should be investigated for the actual intervention rather than answered by a general recovery slogan. An educational article cannot predict those factors for an individual. The absence of a guarantee is not an absence of commitment to care.

A more useful plan sets a review point rather than an unconditional deadline for success. What improvement is expected? How will it be assessed? What happens if it does not occur? These questions make the intervention accountable while leaving room for information that emerges during treatment. They also allow the person to report difficulty without appearing to violate the programme's promised story.

Consider a hypothetical person who gains a valued capacity but judges the outcome against a promise of complete restoration. In this example, the person calls that gain a failure. The example illustrates an objection to the promise; it does not establish how promises affect recipients in practice. Clear outcomes permit progress to count without requiring exaggeration or denial of remaining limitations.

Measurement should serve the person

A measure is useful when its purpose is understood. This article proposes a symptom scale and a selected activity as possible ways to track a clinical target and daily participation, respectively; their validity, responsiveness, and suitability would need to be established for the specific target and population. Neither should be converted into a complete account of identity, worth, or future potential. This article proposes patient-defined goals to keep evaluation connected to the person.

For example, remembering a care plan, sustaining a conversation, or returning to a valued activity may matter more than an abstract promise of optimal brain function. These goals are illustrative and should not be imposed. If a person revises their priorities, the plan should record that revision and discuss its implications rather than treating the original goal as compulsory.

The practical resolution is to make healing language accountable to a specific claim. Name the target, identify the evidence, distinguish the outcome domains, and describe what remains uncertain. Hope can be expansive as a personal experience while clinical claims remain precise. That combination allows meaningful improvement to be recognized without selling a biological conclusion that has not been demonstrated.

Implication for practice and interpretation

The distinction between endpoints should be made before interpreting success. If a programme aims to improve distress, its result should be reported in those terms. If it aims to improve daily participation, that outcome needs appropriate assessment. A biological explanation can be investigated alongside these questions, but it should not replace them. The practical argument is that precise measurement makes improvement more credible and makes lack of improvement more informative; it does not require the person to choose between hope and evidence.

Research context and its limits

Milligan and colleagues’ publication is titled “Loss of PTSD Diagnosis in Response to Evidence-Based Treatments.” [2] The present editorial uses that research as bounded context, not as validation of its hypothetical examples or proposed practical arrangements. Its argument concerns how the question should be understood and discussed. A group finding cannot decide an individual diagnosis, establish the cause of every difficulty, or determine a single appropriate course of care. The population, outcome, and design should remain visible whenever findings are applied beyond the study itself.

Conclusion

The same standard should apply to our own hopes. Wanting complete restoration is understandable. It should not become a condition for recognizing worthwhile progress or a demand that someone claim recovery they do not feel. Smaller gains may be important without being the whole answer.

Healing can remain a meaningful personal word. Scientific and clinical claims need more precision. The most useful account of recovery names what changed, how it was assessed, and what still needs care. Hope becomes more trustworthy when it does not require us to stop asking those questions.

Evidence and disclosure

This is a research-informed educational editorial, not original empirical research or individual medical advice. Constructed examples are hypothetical. Practical applications are editorial proposals unless explicitly attributed to a tested intervention. Scientific claims are tied directly to the external sources listed below. No proprietary recovery efficacy is established. This manuscript was prepared with substantive AI assistance for literature synthesis and drafting.

Source-recency exception ledger: Reference 1, published in 2017, is retained as a historical randomized psychotherapy imaging study illustrating a specific cortical-function endpoint. [1] Its purpose is to distinguish measured neural change from tissue regrowth or everyday functional recovery; it is not presented as current comprehensive treatment evidence. The study population and outcome limitations remain applicable.

References

1. Fonzo GA, et al. Selective Effects of Psychotherapy on Frontopolar Cortical Function in PTSD. American Journal of Psychiatry. 2017;174(12):1175-1184. doi:10.1176/appi.ajp.2017.16091073. https://pubmed.ncbi.nlm.nih.gov/28715907/.

2. Milligan T, et al. Loss of PTSD Diagnosis in Response to Evidence-Based Treatments: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2025;82(7):718-727. doi:10.1001/jamapsychiatry.2025.0695. https://pubmed.ncbi.nlm.nih.gov/40397424/.